Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2022 Earnings Conference Call February 8, 2023 8:00 AM ET

Company Participants

Ran Meir - Senior Vice President, Head of Investor Relations

Richard Francis - Chief Executive Officer

Eli Kalif - Executive Vice President and Chief Financial Officer

Sven Dethlefs - Executive Vice President, North America Commercial

Conference Call Participants

Umer Raffat - Evercore ISI

Gary Nachman - BMO Capital Markets

Glen Santangelo - Jefferies

Jason Gerberry - Bank of America

Balaji Prasad - Barclays

Elliot Wilbur - Raymond James

Christopher Schott - JPMorgan

Rishi Parekh - JPMorgan

Operator

Welcome to the Teva's Fourth Quarter and Full Year 2022 Earnings Call. [Operator Instructions] Please be advised that this conference is being recorded.

I would now like to hand the conference over to our first speaker today, Ran Meir, Senior Vice President, Head of Investor Relations. Please go ahead.

Ran Meir

Thank you, Nadia. Thank you, everyone, for joining us today. We hope you have had an opportunity to review our press release, which was issued earlier this morning. A copy of the press release as well as the copy of the slides being presented on this call can be found on our website at tevapharm.com. Please review our forward-looking statements on Slide 2. Additional information regarding these statements and our non-GAAP financial measures is available on our earnings release and in our SEC Form 10-K and 10-Q.

To begin today's call, Richard Francis, Teva's CEO, will provide an overview of Teva’s 2022 results and business performance, recent events and priorities going forward. Our CFO, Eli Kalif, will follow up for reviewing the financial results in more detail, including our 2022 financial outlook. Joining Richard and Eli on the call today is Sven Dethlefs, Head of North America business, who will be available during the question-and-answer session that will follow the presentation. Please note that today's call will run approximately one hour.

And with that, I will now turn the call over to Richard. Richard, if you would, please?

Richard Francis

Thank you, Ran, and welcome, everyone. I'm excited to be here today, and I'd like to start by saying, it was great meeting many of you in San Francisco JPMorgan last month. And I look forward to getting to know Teva shareholders, investors and analysts, so that you can have an open dialogue going forward. I'm excited to be here because there's a lot of opportunity at Teva. The team has done a tremendous work to get the company back to a solid foundation. And now there's an opportunity to get back to growth.